In uncontrolled hypertension, adding lorundrostat to a standardized AHT regimen reduced SBP at 12 wk [0.03%]
在难治性高血压患者中，与标准抗高血压药联用lorundrostat可降低12周时的收缩压水平
Alena Shantsila,Gregory Y H Lip;ACP Journal Club Editorial Team at McMaster University
Alena Shantsila
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
In patients with bronchiectasis, daily brensocatib reduced annualized pulmonary exacerbation rates [0.03%]
支气管扩张症患者每天接受brensocatib治疗可降低年化肺部恶化率
Holly Keyt;ACP Journal Club Editorial Team at McMaster University
Holly Keyt;ACP Journal Club Editorial Team at McMaster University
GIM/FP/GP: [Formula: see text] Pulmonology: [Formula: see text].
In PAH with high risk for death, sotatercept reduced a composite of death, lung transplantation, or PAH hospitalization >24 h at 9 mo [0.03%]
对于高死亡风险的肺动脉高压患者，在9个月时，sotatercept降低了死亡、肺移植或住院时间超过24小时的复合终点事件的风险
Nicholas S Hill;ACP Journal Club Editorial Team at McMaster University
Nicholas S Hill;ACP Journal Club Editorial Team at McMaster University
GIM/FP/GP: [Formula: see text] Pulmonology: [Formula: see text].
Disproportionate Loneliness Burden Demonstrated in Two National Samples of Working-Age Adults With Varied Disability Types [0.03%]
两类残疾成年人在劳动年龄阶段的非比例孤独感负担——基于两次全国样本调查的结果
Maggie Salinger,Melissa A Clark
Maggie Salinger
Annals On Call - Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control Is Inadequate With Dulaglutide [0.03%]
病例年报-德谷胰岛素控制不佳时逐剂量增加与换用 tirzepatide 的比较
Robert M Centor,Liana K Billings
Robert M Centor
Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians (Version 1, Update Alert 3) [0.03%]
重度抑郁发作成人患者非药物与药物治疗：美国内科医师学院（ACP）急性期重大抑郁症的非药物和药物治疗临床实践指南第1版第3次更新提醒
Amir Qaseem,Douglas K Owens,Itziar Etxeandia-Ikobaltzeta et al.
Amir Qaseem et al.
In adults with active cancer and VTE, extended reduced-dose apixaban was noninferior to full-dose apixaban for VTE recurrence at 1 y [0.03%]
在接受癌症治疗的成人患者中，与全剂量阿哌沙班相比，减量阿哌沙班作为延长抗凝治疗对静脉血栓具有非劣效性
Vasiliki Danilatou;ACP Journal Club Editorial Team at McMaster University
Vasiliki Danilatou;ACP Journal Club Editorial Team at McMaster University
GIM/FP/GP: [Formula: see text] Oncology: [Formula: see text] Hematology: [Formula: see text].